CNR Institutional Research Information System

SANDOMENICO, ANNAMARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.751
NA - Nord America 2.213
EU - Europa 672
SA - Sud America 583
Continente sconosciuto - Info sul continente non disponibili 253
AF - Africa 43
OC - Oceania 4
Totale 6.519
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.105
SG - Singapore 1.079
CN - Cina 681
BR - Brasile 448
VN - Vietnam 311
IT - Italia 281
HK - Hong Kong 272
FR - Francia 145
KR - Corea 127
IN - India 50
BD - Bangladesh 46
CA - Canada 45
GB - Regno Unito 43
NL - Olanda 42
DE - Germania 40
CO - Colombia 36
AR - Argentina 33
JP - Giappone 32
FI - Finlandia 29
ID - Indonesia 27
EC - Ecuador 25
MX - Messico 24
IQ - Iraq 20
IL - Israele 16
ES - Italia 15
RU - Federazione Russa 15
TR - Turchia 12
ZA - Sudafrica 12
PL - Polonia 10
VE - Venezuela 10
CL - Cile 9
PY - Paraguay 9
UA - Ucraina 9
KZ - Kazakistan 8
MY - Malesia 8
PK - Pakistan 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
UZ - Uzbekistan 8
CR - Costa Rica 7
JM - Giamaica 7
IE - Irlanda 6
KE - Kenya 6
MA - Marocco 6
SA - Arabia Saudita 6
SE - Svezia 6
PE - Perù 5
PH - Filippine 5
UY - Uruguay 5
AL - Albania 4
GT - Guatemala 4
PS - Palestinian Territory 4
TN - Tunisia 4
AT - Austria 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HN - Honduras 3
MK - Macedonia 3
PT - Portogallo 3
SI - Slovenia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
SC - Seychelles 2
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CM - Camerun 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
MZ - Mozambico 1
NC - Nuova Caledonia 1
Totale 6.260
Salva come PNG Salva come JPEG
Città #
Singapore 669
Santa Clara 326
Hefei 287
San Jose 273
Hong Kong 262
Ashburn 154
Council Bluffs 134
Lauterbourg 126
Seoul 125
Ho Chi Minh City 114
Beijing 111
Los Angeles 68
Hanoi 62
Dallas 48
Naples 42
Princeton 42
São Paulo 36
New York 29
Rome 25
Milan 21
Frankfurt am Main 20
Abbeville 19
Afragola 18
Buffalo 17
Helsinki 17
Casandrino 15
Chicago 15
Minamishinagawa 15
Bengaluru 14
Da Nang 14
Tokyo 14
Atlanta 12
Haiphong 12
Quito 12
Belo Horizonte 11
Brasília 11
Lappeenranta 11
Brooklyn 10
Montreal 10
Philadelphia 10
Phoenix 10
Portsmouth 10
Marigliano 9
Rio de Janeiro 9
Baghdad 8
Denver 8
Dhaka 8
Medellín 8
Miami 8
Orem 8
Soccavo 8
Tashkent 8
Amsterdam 7
Boardman 7
Guayaquil 7
Warsaw 7
Alexandria 6
Asunción 6
Biên Hòa 6
Bogotá 6
Boston 6
Brescia 6
Chennai 6
Goiânia 6
Guangzhou 6
Las Vegas 6
London 6
Nairobi 6
San José 6
Springfield 6
Terni 6
The Bronx 6
Washington 6
Almaty 5
Baltimore 5
Charlotte 5
Curitiba 5
Genoa 5
Hải Dương 5
Indianapolis 5
Johannesburg 5
Kingston 5
Madrid 5
Mexico City 5
Queens 5
Quảng Ngãi 5
Salvador 5
Santiago 5
Seattle 5
Shenzhen 5
Stockholm 5
Tampa 5
The Dalles 5
Arlington 4
Bangkok 4
Bari 4
Barretos 4
Bexley 4
Caracas 4
Dublin 4
Totale 3.591
Salva come PNG Salva come JPEG
Nome #
Human IgG1 antibodies suppress angiogenesis in a target-independent manner. 240
A structure-based approach for the development of a bicyclic peptide acting as a miniaturized anti-CD55 antibody 132
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelialN-formyl peptide receptor 3 102
Exploring the Interaction between the SWI/SNF Chromatin Remodeling Complex and the Zinc Finger Factor CTCF 101
Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation 95
Monoclonal antibodies: A prospective and retrospective view 87
Structural insights into the interaction of a monoclonal antibody and Nodal peptides by STD-NMR spectroscopy 86
Recent applications of retro-inverso peptides 85
Preparation and In Vitro Evaluation of RITUXfab-Decorated Lipoplexes to Improve Delivery of siRNA Targeting C1858T PTPN22 Variant in B Lymphocytes 84
Members of the GADD45 protein family show distinct propensities to form toxic amyloid-like aggregates in physiological conditions 84
Recombinant humanized Fab fragments targeting the CFC domain of human Cripto-1 84
Selection of a nuclease‐resistant rna aptamer targeting cd19 81
Unveiling CD59-Antibody Interactions to Design Paratope-Mimicking Peptides for Complement Modulation 81
Self-association regions in the CARD of Bcl-10 75
Pixeled metasurface for multiwavelength detection of vitamin D 75
Advanced Lab-on-Fiber Optrodes Assisted by Oriented Antibody Immobilization Strategy 73
Mid-infrared enhanced spectrochemical detection using azide vibrational probes 72
Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry 71
Screening of beta-hairpin peptide-engrafted 1,2,3-triazoles to identify APEH enzyme inhibitors 68
Insights into the interaction mechanism of dtp3 with mkk7 by using std-nmr and computational approaches 68
Production in Bacteria and Characterization of Engineered Humanized Fab Fragment against the Nodal Protein 67
Selective inhibition of acylpeptide hydrolase in SAOS-2 osteosarcoma cells: is this enzyme a viable anticancer target? 67
Human carbonic Anydrase VII protects cells from oxidative damage 65
Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation 64
Generation and testing of engineered multimeric Fabs of trastuzumab 64
Evolution of escherichia coli expression system in producing antibody recombinant fragments 64
CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma 63
Beyond the Diagnosis: Generation of Neutralizing Anti-Nodal Monoclonal Antibodies a Novel and Promising Therapeutic Approach in Melanoma and More 62
High sensitive reflection type long period fiber grating biosensor for real time detection of Thyroglobulin, a differentiated thyroid cancer biomarker: The "Smart Health" Project 62
Oxidized Substrates of APEH as a Tool to Study the Endoprotease Activity of the Enzyme 62
Synthetic Peptide Libraries. From random mixtures to in vivo testing. 62
Polypeptide Antagonists of IgE-FceRI interaction 59
Cripto-1: an extracellular protein - connecting the sequestered biological dots 59
Protein-protein interactions and peptide antagonists 59
A recent update on the use of microbial transglutaminase for the generation of biotherapeutics 59
New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding. 58
Intrinsic structural versatility of the highly conserved 412-423 epitope of the Hepatitis C Virus E2 protein 58
Targeting VEGF receptors with non-neutralizing cyclopeptides for imaging applications. 57
Investigating the oxidative refolding mechanism of Cripto-1 CFC domain 56
The role of Nodal and Cripto-1 in human oral squamous cell carcinoma 56
Branched peptides for the modulation of protein-protein interactions: More arms are better than one? 55
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 55
Structure-based design of small bicyclic peptide inhibitors of Cripto-1 activity 55
A comparative analysis of catalytic activity and stability of microbial transglutaminase in controlled denaturing conditions 55
APEH Inhibition Affects Osteosarcoma Cell Viability via Downregulation of the Proteasome. 54
Expression and purification of the D4 region of PLD1 and characterization of its interaction with PED-PEA15 53
A NOVEL AND HIGHLY SELECTIVE IgE-BINDING PEPTIDE WITH ANTI-ALLERGIC PROPERTIES: AN SPR AND CELL-BASED STUDY 53
A multianalytical approach to investigate the effect of nanofiltration on plasma-derived factor IX clinical lots 52
Disclosing the interaction of carbonic anhydrase ix with cullin-associated nedd8-dissociated protein 1 by molecular modeling and integrated binding measurements. 51
Evaluation of combined use of Oxyma and HATU in aggregating peptide sequences 50
Long period fiber grating nano-optrode for cancer biomarker detection 47
A new Fc?RI receptor-mimeti peptide (PepE) that blocks IgE binding to its high affinity receptor and prevents mediator release from RBL 2H3 cells 45
MONOCLONAL ANTIBODIES ABLE TO BIND THE VIRAL HCV E2 PROTEIN PREPARATION AND USE THEREOF 45
Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models 44
Small Peptide inhibitors of acetyl-Peptide hydrolase having an uncommon mechanism of inhibition and a stable bent conformation. 44
The LQSP tetrapeptide is a new highly efficient substrate of microbial transglutaminase for the site-specific derivatization of peptides and proteins 44
A new role of Human Carbonic Anhydrase VII in the protection of the cells from oxidative damage 42
Design, synthesis and characterization of peptides mimicking hCA IX IC tail able to interact with nuclear transport factors 42
Monoclonal antibodies against pools of mono- and polyacetylated peptides selectively recognize acetylated lysines within the context of the original antigen 41
Probing the interaction interface of the GADD45 beta/MKK7 and MKK7/DTP3 complexes by chemical cross-linking mass spectrometry 40
Automatic procedures for the synthesis of difficult peptides using oxyma as activating reagent: A comparative study on the use of bases and on different deprotection and agitation conditions 39
De novo sequencing and characterization of a novel Bowman-Birk inhibitor from Lathyrus sativus L. seeds by electrospray mass spectrometry 37
Trifluoroacetylated tyrosine-rich D-tetrapeptides have potent antioxidant activity 37
Peptide mimics of the IgE high affinity receptor Fc?RI?. 36
Peptide mimics of the IgE high affinity receptor FceRIa 36
A novel and highly selective IgE binding peptide with anti allergic properties 36
Conformational features and binding affinities to Cripto, ALK7 and ALK4 of Nodal synthetic fragments 36
High sensitive long period fiber grating biosensor for cancer biomarker detection 36
Peptides mimicking IC tail of hCA IX tumor enzyme interact with nuclear transport factors 36
Generation and characterization of monoclonal antibodies against a cyclic variant of hepatitis C virus E2 epitope 412-422 36
APEH-mediated downregulation of proteasome by a potential anticancer peptide. 36
A protein-based biointerfacing route toward label-free immunoassays with long period gratings in transition mode 35
Lab-on-Fiber biosensing for cancer biomarker detection 35
A novel and higy selective IgE-binding peptide with anti-allergic properties: an SPR and cell-based study 34
Cysteine co-oxidation process driven by native peptide folding: an example on HER2 receptor model system 34
A new FcepsilonRI receptor-mimetic peptide (PepE) that blocks IgE binding to its high affinity receptor and prevents mediator release from RBL 2H3 cells . 34
A novel and higly selective IgE-binding peptide with anti-allergic properties: an SPR and cell-based study. 34
Transglutaminase Glutamine containing consensus sequence for identification of conjugation site of proteins by mass spectroscopy 33
A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling 33
DESIGN, SYNTHESIS AND CHARACTERIZATION OF PEPTIDES MIMICKING hCA IX TAIL ABLE TO INTERACT WITH NUCLEAR TRANSPORT FACTORS. 33
Investigating the substrate specificity and use of MTGase to graft peptide synthons onto proteins. 32
Fluorescence study for selecting specific ligands toward HER2 receptor: An example of receptor fragment approach 32
Characterization of Carbonic Anhydrase IX Interactome Reveals Proteins Assisting Its Nuclear Localization in Hypoxic Cells 32
IgE-binding properties and selectivity of peptide mimics of the FcvarepsilonRI binding site 32
Multifaceted antibodies development against synthetic alpha-dystroglycan mucin glycopeptide as promising tools for dystroglycanopathies diagnostic 31
Clinical proof of concept for a safe and effective NF-kappa B-targeting strategy in multiple myeloma 31
De novo design of Nodal mimetic peptides 31
Structural versatility of Hepatitis C virus proteins: Implications for the design of novel anti-HCV intervention strategies 30
A comparative structural and bioanalytical study of IVIG clinical lots 30
Cancer-Selective Targeting of the NF-kappa B Survival Pathway with GADD45 beta/MKK7 Inhibitors 30
Pegylated Trastuzumab Fragments Acquire an Increased in Vivo Stability but Show a Largely Reduced Affinity for the Target Antigen 30
A simplified and automated perspective for the screening of universal synthetic peptide libraries 30
Fluorescence study for selecting specific ligands toward HER2 receptor: An example of receptor fragment approach 30
Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers 30
Inhibition of pathological angiogenesis antagonizing VEGF receptor I. 30
Peptide antagonists of protein-protein interactions identified by screening protein fragments derived by enzyme degradation 29
Peptide models as substrates for mTGAse catalysed reaction. 29
Preclinical toxicology and safety pharmacology of the first-in-class GADD45 beta/MKK7 inhibitor and clinical candidate, DTP3 29
HER2-DIVMP: Synthetic model of HER2 receptor validated for selecting new HER2-binding ligands 29
A. Caporale, F. Selis, A. Sandomenico, G. Tonon, M. Ruvo. Investigating the substrate specificity and use of MTGase to graft peptide synthons onto proteins 29
Totale 5.346
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.601
article - articoli 15.179
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.780
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202443 0 0 0 0 0 0 0 0 0 0 38 5
2024/20251.947 16 7 199 103 262 128 48 93 122 55 526 388
2025/20263.263 194 443 350 454 523 124 527 148 132 185 114 69
2026/20271.266 196 329 383 358 0 0 0 0 0 0 0 0
Totale 6.519